Nov 4 (Reuters) - Medicure Inc MPH.V :
* MEDICURE ANNOUNCES THAT THE SHORTENED AGGRASTAT® VERSUS INTEGRILIN® IN PERCUTANEOUS CORONARY INTERVENTION (SAVI-PCI) STUDY HAS MET ITS PRIMARY ENDPOINT
Source text for Eikon: ID:nCNW6qSwXa Further company coverage: MPH.V
((Reuters.Briefs@thomsonreuters.com;))